Millipore Sigma Vibrant Logo

AM46 Anti-Caspase-8 (Ab-3) Mouse mAb (1-3)

Anti-Caspase-8, mouse mAb, clone 1-3, recognizes ~55-58 kDa latent form in non-apoptotic Jurkat cells & ~18 kDa active form in apoptotic Jurkat & HeLa cells. It is validated for Western blotting.

Anti-Caspase-8 (Ab-3) Mouse mAb (1-3): Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: Anti-MACH, Anti-FLICE, Anti-CAP4, Anti-CASP8, Anti-Mch5, Anti-ICE-LAP5

AM46
  
Recuperando precio...
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Maximum Quantity is
Al finalizar el pedido Más información
Ahorró ()
 
—
Solicitar precio
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

       

      Póngase en contacto con el Servicio de Atención al Cliente

      Descripción

      Replacement Information

      Tabla espec. clave

      Species ReactivityHostAntibody Type
      HMMonoclonal Antibody
      Description
      Overview

      This product has been discontinued.



      Recognizes the ~55-58 kDa latent form of caspase-8 in non-apoptotic Jurkat cells and with ~18 kDa active form in apoptotic Jurkat or HeLa cells. Additional proteins at ~42-44 kDa corresponding to the heavier processed chain may appear in some apoptotic cell lines.
      Catalogue NumberAM46
      Brand Family Calbiochem®
      SynonymsAnti-MACH, Anti-FLICE, Anti-CAP4, Anti-CASP8, Anti-Mch5, Anti-ICE-LAP5
      References
      ReferencesSmyth, L.A. and Brady, H.J.M. 2005. Hypertension 46, 100.
      Fearnhead, H.O., et al. 1998. Proc. Natl. Acad. Sci. USA 95, 13664.
      Juo, P., et al. 1998. Curr. Biol. 8, 1001.
      Martin, D.A., et al. 1998. J. Biol. Chem. 273, 4345.
      Peter, M.E. and Krammer, P.H. 1998. Curr. Opin. Immunol. 10, 545.
      Sakamaki, K., et al. 1998. Eur. J. Biochem. 253, 399.
      Stennicke, H.R., et al. 1998. J. Biol. Chem. 273, 27084.
      Scaffifi, C., et al. 1997. J. Biol. Chem. 272, 26953.
      Stennicke, H.R. and Salvesen, G.S. 1997. J. Biol. Chem. 272, 25719.
      Muzio, M., et al. 1996. Cell 85, 817.
      Kischkel, F.C., et al. 1995. EMBO J. 14, 5579.
      Product Information
      FormLiquid
      FormulationIn 0.05 M sodium phosphate buffer, 0.2% gelatin.
      Negative controlAnti-trpE (Ab-1) Mouse mAb (I22-25) (Cat. No. OB01)
      Positive controlHeLa or Jurkat cells
      Preservative≤0.1% sodium azide
      Applications
      Key Applications Immunoblotting (Western Blotting)
      Not Frozen Sections
      Not Immunofluorescence
      Not Immunoprecipitation
      Not Paraffin Sections
      Application NotesImmunoblotting (1 µg/ml)
      Frozen Sections (not recommended)
      Immunofluorescence (not recommended)
      Immunoprecipitation (not recommended)
      Paraffin Sections (not recommended)
      Application CommentsAdditional bands at ~42-44 kDa corresponding to the heavier processed chain may appear in some apoptotic cell lines. Antibody should be titrated for optimal results in individual systems.
      Biological Information
      Immunogenhuman recombinant caspase-8
      ImmunogenHuman
      Clone1-3
      HostMouse
      IsotypeIgG₁
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Do not freeze Yes
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      AM46 0

      Documentation

      Anti-Caspase-8 (Ab-3) Mouse mAb (1-3) Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      Anti-Caspase-8 (Ab-3) Mouse mAb (1-3) Certificados de análisis

      CargoNúmero de lote
      AM46

      Referencias bibliográficas

      Visión general referencias
      Smyth, L.A. and Brady, H.J.M. 2005. Hypertension 46, 100.
      Fearnhead, H.O., et al. 1998. Proc. Natl. Acad. Sci. USA 95, 13664.
      Juo, P., et al. 1998. Curr. Biol. 8, 1001.
      Martin, D.A., et al. 1998. J. Biol. Chem. 273, 4345.
      Peter, M.E. and Krammer, P.H. 1998. Curr. Opin. Immunol. 10, 545.
      Sakamaki, K., et al. 1998. Eur. J. Biochem. 253, 399.
      Stennicke, H.R., et al. 1998. J. Biol. Chem. 273, 27084.
      Scaffifi, C., et al. 1997. J. Biol. Chem. 272, 26953.
      Stennicke, H.R. and Salvesen, G.S. 1997. J. Biol. Chem. 272, 25719.
      Muzio, M., et al. 1996. Cell 85, 817.
      Kischkel, F.C., et al. 1995. EMBO J. 14, 5579.

      Folleto

      Cargo
      Caspases and other Apoptosis Related Tools Brochure

      Citas

      Título
    • Cecile Tetaud, et al. (2003) Two Distinct Gb3/CD77 Signaling Pathways Leading to Apoptosis are Triggered by Anti-Gb3/CD77 mAb and Verotoxin-1. Journal of Biological Chemistry 278, 45200-45208.
      		•
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision17-August-2007 RFH
      SynonymsAnti-MACH, Anti-FLICE, Anti-CAP4, Anti-CASP8, Anti-Mch5, Anti-ICE-LAP5
      ApplicationImmunoblotting (1 µg/ml)
      Frozen Sections (not recommended)
      Immunofluorescence (not recommended)
      Immunoprecipitation (not recommended)
      Paraffin Sections (not recommended)
      DescriptionPurified mouse monoclonal antibody. Recognizes the ~56-58 kDa latent and the ~18 kDa active form of caspase-8.
      BackgroundCaspase-8 (ICE-LAP5, MACH, FLICE, CAP4) is the most proximal of the members of the apoptotic caspase cascade. Caspase-8 is directly involved in apoptosis mediated through either Fas or the TNF receptor and forms one of the key components of the transducing DISC, the CAP4 protein. Cell lines that are deficient in caspase-8 are resistant to Fas mediated apoptosis. Nine different isoforms of caspase 8 have been identified but the "a" and "b" isoforms show the highest expression at the level of protein in multiple tissues. Caspase-8 has a pH optimum of 6.8 and has a kcat/Km of 8.7 X 105 M-1 s-1. The pro-form of caspase-8 has a molecular weight of approximately 55 kDa and undergoes several processing steps to generate the active heterodimer of p18 and p10/12. In addition to activation via Fas, oligomerization of caspase-8 at the cell membrane and interaction with Granzyme B and caspase 10 will induce auto-processing and activation of the apoptotic pathway. The mouse caspase-8 gene has also been identified and is expressed in the adult as well as at high levels in the day 9.5 and day 17.5 embryo suggesting a role in development.
      HostMouse
      Immunogen speciesHuman
      Immunogenhuman recombinant caspase-8
      Clone1-3
      IsotypeIgG₁
      Specieshuman
      Positive controlHeLa or Jurkat cells
      Negative controlAnti-trpE (Ab-1) Mouse mAb (I22-25) (Cat. No. OB01)
      FormLiquid
      FormulationIn 0.05 M sodium phosphate buffer, 0.2% gelatin.
      Concentration Label Please refer to vial label for lot-specific concentration
      Preservative≤0.1% sodium azide
      CommentsAdditional bands at ~42-44 kDa corresponding to the heavier processed chain may appear in some apoptotic cell lines. Antibody should be titrated for optimal results in individual systems.
      Storage +2°C to +8°C
      Do Not Freeze Yes
      Toxicity Standard Handling
      ReferencesSmyth, L.A. and Brady, H.J.M. 2005. Hypertension 46, 100.
      Fearnhead, H.O., et al. 1998. Proc. Natl. Acad. Sci. USA 95, 13664.
      Juo, P., et al. 1998. Curr. Biol. 8, 1001.
      Martin, D.A., et al. 1998. J. Biol. Chem. 273, 4345.
      Peter, M.E. and Krammer, P.H. 1998. Curr. Opin. Immunol. 10, 545.
      Sakamaki, K., et al. 1998. Eur. J. Biochem. 253, 399.
      Stennicke, H.R., et al. 1998. J. Biol. Chem. 273, 27084.
      Scaffifi, C., et al. 1997. J. Biol. Chem. 272, 26953.
      Stennicke, H.R. and Salvesen, G.S. 1997. J. Biol. Chem. 272, 25719.
      Muzio, M., et al. 1996. Cell 85, 817.
      Kischkel, F.C., et al. 1995. EMBO J. 14, 5579.
      Citation
    • Cecile Tetaud, et al. (2003) Two Distinct Gb3/CD77 Signaling Pathways Leading to Apoptosis are Triggered by Anti-Gb3/CD77 mAb and Verotoxin-1. Journal of Biological Chemistry 278, 45200-45208.
      		•

      Productos y aplicaciones relacionados

      Related Products

      Número de referencia Descripción  
      AM46T Anti-Caspase-8 (Ab-3) Mouse mAb (1-3) Precios y disponibilidad

      Related Products

      Número de referencia Descripción  
      AM46T Anti-Caspase-8 (Ab-3) Mouse mAb (1-3) Precios y disponibilidad

      Categorías

      Life Science Research > Antibodies and Assays > Primary Antibodies